Impaired myocardial relaxation with exercise determines peak aerobic exercise capacity in heart failure with preserved ejection fraction

在射血分数保留的心力衰竭患者中,运动时心肌舒张功能受损决定了其有氧运动峰值能力。

阅读:1

Abstract

BACKGROUND: Heart failure with preserved ejection fraction (HFpEF) is a clinical syndrome characterized by impaired exercise capacity due to shortness of breath and/or fatigue. Assessment of diastolic dysfunction at rest and with exercise may provide insight into the pathophysiology of exercise intolerance in HFpEF. AIMS: To measure echocardio-Doppler-derived parameters of diastolic function as they relate to various indices of aerobic exercise capacity in HFpEF. METHODS: We selected 16 subjects with clinically stable HFpEF, no evidence of volume overload, but impaired functional capacity by cardiopulmonary exercise testing [peak oxygen consumption (VO(2) )]. We measured the transmitral E and A flow velocities, E/A ratio, and E deceleration time (DT) and tissue Doppler E' velocity. We also indexed the E' to the DT, as additional measure of impaired relaxation (E'(DT) ), and calculated the diastolic functional reserve index (DFRI), as the product of E' at rest and change in E' with exercise. RESULTS: E' velocity, at rest and peak exercise, as well as the DFRI positively correlated with peak VO(2) , whereas DT, E'(DT) , and E/E' with exercise inversely correlated with peak VO(2) . Of note, the E'(DT) at rest also significantly predicted E' velocity at peak exercise (R = +0.81, P < 0.001). Exercise E' was the only independent predictor of peak VO(2) at multivariable analysis (R = +0.67, P = 0.005). CONCLUSIONS: The E' velocity at peak exercise is a strong and independent predictor of aerobic exercise capacity as measured by peak VO(2) in patients with HFpEF, providing the link between abnormal myocardial relaxation with exercise and impaired aerobic exercise capacity in HFpEF.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。